InMare
INMARE stands for “Industrial Applications of Marine Enzymes: Innovative screening and expression platforms to discover and use the functional protein diversity from the sea”. It is a collaborative Innovation Action to streamline the pathways of discovery and industrial applications of new marine enzymes and bioactives for targeted production of fine chemicals, drugs and in environmental clean-up applications.
The INMARE consortium will unify the multidisciplinary expertise and facilities of academic and industry partners. This will include integrating the following core activities: advanced technologies to access and sample unique marine biodiversity hot-spots; state-of-the art technologies for construction of metagenomic libraries; innovative enzyme screening assays and platforms; cutting-edge sequence annotation pipelines and bioinformatics resources; high-end activity screening technology; bioanalytical and bioprocess engineering facilities and expertise, nanoparticle-biocatalysts; high-quality protein crystallization and structural analysis facilities and experts in IP management for biotechnology.
The companies involved in the project are market leaders in enzyme production and biocatalysis processes designed to efficiently deliver safer (pharmaceuticals) cheaper (agriculture) and biobased (biopolymers) products. They also have impressive track record in environmental clean-up technologies and are committed to promoting public understanding, awareness and dissemination of scientific research. The main emphasis will be focused on streamlining and shortening the pipelines for enzyme and ‘bioactive compound’ discovery towards industrial applications through the establishing of marine enzyme collections with a high proportion of enzymes-“allrounders”. The project will also prioritize the identification of novel lead products and the delivery of improved prototypes for new biocatalytic processes.
Project webpage Open project webpage Start year 18/02/2015 End year 31/03/2019 ID ID: 634486 iBB Role Partner iBB Budget 309 663,75 € Research Group BERG PI Joaquim Cabral, Carla Carvalho Project Partners Bangor University (Coord.), UH-University of Hamburg, HHU- Heinrich Heine University of Düsseldorf, CNR- Consiglio Nazionale delle Ricerche, CSIC-Agencia Estatal Consejo Superior de Investigaciones Científica, Bayer Technology Services GmbH, Novozymes A/S, University of Bergen, BIOMERIT Research Centre Cork, Vilnius University, Technical University of Crete, UNIBO-Alma Mater Studiorum Università di Bologna, evocatal GmbH, INOFEA Ltd., Jacobs University, Pharma Mar S.A., FHNW- University of Applied Sciences and Arts, LSE-London School of Economics and Political Science, CLIB- Cluster Industrial Biotechnology, Faculty of Chemical Engineering, University of Toronto, Seascape Consultants Ltd, UiU- Uni Research Centre for Applied Biology, Bergen, UNIMI- University of Milan Status Completed Funding H2020